Talkspace materials describe a nationwide virtual platform with thousands of licensed clinicians and access through insurers and employers.
The service supports live video, audio, chat, and messaging therapy, giving users several online communication routes within its behavioral-health network.
Talkspace does not prescribe controlled substances, so it cannot treat ADHD with stimulants and refers patients who need those drugs to in-person or primary care prescribers. It competes with larger, better-funded virtual care rivals including Teladoc, Lyra Health, Amwell, and Spring Health, and with health plans and health systems that build their own teletherapy tools.
Insurance payors and employee assistance programs generate about three-quarters of Talkspace's revenue at contracted in-network rates, and a few large customers supply a material share whose loss or renegotiation would cut sales. Its consumer subscription business fell 29.5% in 2025 to $17.5 million, leaving little direct-to-consumer revenue outside payer contracts.
Talkspace offers virtual therapy for individuals, couples, and teens, alongside psychiatry, medication management, self-guided tools, and Tee, an AI mental-health guide.
Its official service navigation also includes insurance and employer access, military and veteran pathways, and other focused therapy programs.
